Evidence map›Paper›PMID 27180929›Full record

ArticleJournal of diabetes investigation2016

Vitamin D and its receptor regulate lipopolysaccharide-induced transforming growth factor-β, angiotensinogen expression and podocytes apoptosis through the nuclear factor-κB pathway.

Lijuan Xu, Pengyuan Zhang, Hongyu Guan, Zhimin Huang, Xiaoying He, Xuesi Wan, Haipeng Xiao, Yanbing Li

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Impact of vitamin D and vitamin D receptor activator in diabetic nephropathy.Frontiers in clinical diabetes and healthcare · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Vitamin D and Glomerulonephritis.Medicina (Kaunas, Lithuania) · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lijuan XuDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Pengyuan ZhangDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Hongyu GuanDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zhimin HuangDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiaoying HeDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xuesi WanDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Haipeng XiaoDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yanbing LiDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
The First Affiliated Hospital, Sun Yat-sen University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionTo investigate the effects of vitamin D and its receptor on cytokines expression and podocytes apoptosis. MATERIALS AND

methodsCultured mouse podocytes were pre-incubated with vitamin D or transiently transfected with small interfering ribonucleic acid (RNA) to knock down the vitamin D receptor. Lipopolysaccharide was used to mimic the inflammation status of diabetes.

resultsIn a lipopolysaccharide-induced state, expressions of transforming growth factor-β, angiotensinogen and vascular endothelial growth factor were similarly increased. Transforming growth factor-β and angiotensinogen levels originally elevated by lipopolysaccharide challenge were distinctly reduced after pre-incubation with vitamin D. Whereas after vitamin D receptor small interfering (si)RNA transfection, the aforementioned cytokines had opposite changes as expected. However, neither vitamin D pretreatment nor vitamin D receptor siRNA transfection influenced the previously increased vascular endothelial growth factor expression at messenger RNA or protein levels. When pretreated with vitamin D, decreases were observed for phosphorylated inhibitor-κB and the inhibitor kinase proteins. After siRNA transfection, those proteins levels were further elevated. The originally increased transforming growth factor-β and angiotensinogen levels as a result of lipopolysaccharide stimulation were reduced at both the messenger RNA and protein levels after the specific inhibition of the nuclear factor-κB pathway with pyrrolidine dithiocarbamate. The apoptosis rate of podocytes was decreased in a parallel manner after vitamin D pre-incubation, and increased after siRNA transfection, which was also suppressed by pyrrolidine dithiocarbamate.

conclusionsVitamin D and its receptor might be involved in the progression of diabetic nephropathy by regulating transforming growth factor-β, angiotensinogen expression and apoptosis of podocytes. The processes are mediated through the signaling of nuclear factor-κB pathway.

Indexed as

ApoptosisAngiotensinogenAnimalsCells, CulturedInflammationLipopolysaccharidesMiceNF-kappa BPodocytesReceptors, CalcitriolSignal TransductionTransforming Growth Factor betaVitamin DAngiotensinogenLipopolysaccharidesNF-kappa BReceptors, CalcitriolTransforming Growth Factor betaVitamin DNephropathyPodocyteVitamin D

Identifiers

PMID27180929
PMCPMC5009129
OpenAlexW2277805441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.